Search results
Results from the WOW.Com Content Network
The American Medical Association (AMA) Physician Professional Data (formerly known as the AMA Physician Masterfile) includes current and historical data on all physicians, including AMA members and nonmembers, and graduates of foreign medical schools who reside in the United States and who have met the educational and credentialing requirements necessary for recognition as physicians. [1]
The National Council for Prescription Drug Programs (NCPDP) is an American nonprofit standards development organization representing most sectors of the U.S. pharmacy services industry. It was founded in 1977 as the extension of a Drug Ad Hoc Committee that made recommendations for the U.S. National Drug Code (NDC).
In 2007, after other three-year programs in the nation had closed, LECOM was the first US medical school to re-introduce a three-year medical school program. [16] In 2008, LECOM received approval to open an additional branch campus in Greensburg, Pennsylvania at the site of Seton Hill University, [ 17 ] which opened in 2009. [ 18 ]
According to data reported by The Henry J. Kaiser Family Foundation in 2017, 45% of non-elderly adults do not have medical insurance because of cost. [2] Those who are "medically indigent earn too much to qualify for Medicaid but too little to purchase either health insurance or health care."
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
In a clinical trial involving human subjects, a set of content known as a trial master file (TMF) must be produced in accordance with applicable international and local regulations.
Title: Exhibit 46 Author: gshapiro Created Date: 9/16/2015 1:22:17 PM
Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand-name or generic drugs. [1] The REMS program was formalized in 2007.